James Anthony Wigginton
Direktor/Vorstandsmitglied bei ATF Group (PDF) Ltd.
Profil
James Anthony Wigginton is currently a Director at ATF Group (PDF) Ltd.
He was previously an Independent Non-Executive Director at ViaGold Rare Earth Resources Holdings Ltd.
from 1998 to 2014.
He was also a Director at Evivar Medical Pty Ltd.
Aktive Positionen von James Anthony Wigginton
Unternehmen | Position | Beginn |
---|---|---|
ATF Group (PDF) Ltd.
ATF Group (PDF) Ltd. Financial ConglomeratesFinance Part of The Australian Technology Fund Pty Ltd., ATF Group (PDF) Ltd. offers tax management services to remove the time and stress of managing tax affairs for businesses. The Australian company provides specialized expertise and advice in taxation, accounting, BAS agent, tax returns, and company setup. Additionally, they offer meeting room rental and services related to accounting, bookkeeping, business accounting, tax accounting, finance, and SMSF. The company's tax returns are done efficiently and are easy to understand. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James Anthony Wigginton
Unternehmen | Position | Ende |
---|---|---|
VIAGOLD RARE EARTH RESOURCES HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 20.06.2014 |
Evivar Medical Pty Ltd.
Evivar Medical Pty Ltd. Medical/Nursing ServicesHealth Services Evivar Medical is a joint venture company established in February 2006 to provide accurate and timely Hepatitis B therapy management through its SeqHepB system - a web-based decision support tool to assist physicians to optimise and individualise the treatment schedule of patients with chronic hepatitis B. The SeqHepB system can be used to identify HBV mutations present in the patient and to determine resistance levels to the various available antiviral therapies. SeqHepB is a unique viral genomics sequence analysis program that is linked to a HBV genomic database. Evivar Medical joint venture partners are Melbourne Health (including the Victorian Infectious Diseases Reference Laboratory [VIDRL]), Melbourne Health Collaborative Consortium Partners (including leading clinicians from Australia, the Netherlands, Germany and Spain) and the ATF Group (PDF) Limited. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
ViaGold Rare Earth Resources Holdings Ltd.
ViaGold Rare Earth Resources Holdings Ltd. Finance/Rental/LeasingFinance ViaGold Rare Earth Resources Holdings Ltd. is an investment holding company, which engages in the process and production of rare earth, education management and leasing activities. It operates through the following segments: Rare Earth Refining and Separation; Leasing and Capital Financing; and Provision of Consultancy and Management Services to Educate Institutions. The company was founded on August 18, 1995 and is headquartered in Zhuhai, China. | Finance |
ATF Group (PDF) Ltd.
ATF Group (PDF) Ltd. Financial ConglomeratesFinance Part of The Australian Technology Fund Pty Ltd., ATF Group (PDF) Ltd. offers tax management services to remove the time and stress of managing tax affairs for businesses. The Australian company provides specialized expertise and advice in taxation, accounting, BAS agent, tax returns, and company setup. Additionally, they offer meeting room rental and services related to accounting, bookkeeping, business accounting, tax accounting, finance, and SMSF. The company's tax returns are done efficiently and are easy to understand. | Finance |
Evivar Medical Pty Ltd.
Evivar Medical Pty Ltd. Medical/Nursing ServicesHealth Services Evivar Medical is a joint venture company established in February 2006 to provide accurate and timely Hepatitis B therapy management through its SeqHepB system - a web-based decision support tool to assist physicians to optimise and individualise the treatment schedule of patients with chronic hepatitis B. The SeqHepB system can be used to identify HBV mutations present in the patient and to determine resistance levels to the various available antiviral therapies. SeqHepB is a unique viral genomics sequence analysis program that is linked to a HBV genomic database. Evivar Medical joint venture partners are Melbourne Health (including the Victorian Infectious Diseases Reference Laboratory [VIDRL]), Melbourne Health Collaborative Consortium Partners (including leading clinicians from Australia, the Netherlands, Germany and Spain) and the ATF Group (PDF) Limited. | Health Services |